| |
|
|
|
HTG Molecular Diagnostics- Inc.  
|
|
3.5101 -0.02 (-0.01%) |
06-20 14:54 |
|
Open: |
3.53 |
Pre close: |
3.53 |
Target:
|
4.63
|
|
High: |
3.59 |
Low: |
3.45 |
Resistance:
|
3.96
4.34
|
|
Volume: |
568,017 |
Market Cap: |
100M |
Support:
|
3.35
2.79
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.62
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
3.78 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
4.01 |
Stochastic Oscillator |
%K(14,3):
|
8.36 |
|
MA(250): |
2.98  |
%D(3): |
13.89 |
|
Average Volume(K) |
3-Month: |
64715
|
52-Week |
High:
|
5.83 |
|
10-Days: |
55787 |
Low: |
1.59 |
|
RSI |
RSI(14):
|
40.76 |
Change(%): |
29.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.430 |
Return on Equity (ttm) |
-202.6 |
Shares Out. (M) |
28.37 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-55.7 |
Shares Float (M) |
27.82 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.480 |
Qtrly Rev. Growth |
442.2 |
% Held by Institutions |
41.60 |
|
Forward EPS |
-0.720 |
Gross Profit (p.s.) |
0.111 |
Shares Short (K) |
3551 |
|
Book Value (p.s.) |
3.500 |
EBITDA (p.s.) |
-0.352 |
P/E |
-2.47 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.01 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-16.57 |
P/S |
72047552.00 |
|
Operating Margin |
-120.07 |
Levered Free Cash Flow
(M) |
-10.38 |
P/CF |
-6.04 |
|
|
|
|
|
|
